BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 31629111)

  • 1. Increased levels of inflammatory biomarker CX3CL1 in patients with chronic obstructive pulmonary disease.
    Hao W; Li M; Zhang C; Zhang Y; Du W
    Cytokine; 2020 Feb; 126():154881. PubMed ID: 31629111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
    Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of chronic obstructive pulmonary disease with 'exacerbator with emphysema phenotype' is associated with potential biomarkers.
    Hao W; Li M; Zhang Y; Zhang C; Wang P
    Postgrad Med J; 2020 Jan; 96(1131):28-32. PubMed ID: 31375557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory mediators in exhaled breath condensate and peripheral blood of healthy donors and stable COPD patients.
    Hao W; Li M; Zhang C; Zhang Y; Wang P
    Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):224-230. PubMed ID: 31046512
    [No Abstract]   [Full Text] [Related]  

  • 5. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
    Brajer B; Batura-Gabryel H; Nowicka A; Kuznar-Kaminska B; Szczepanik A
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease.
    Bchir S; Nasr HB; Bouchet S; Benzarti M; Garrouch A; Tabka Z; Susin S; Chahed K; Bauvois B
    J Cell Mol Med; 2017 Jul; 21(7):1280-1291. PubMed ID: 28004483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Radicioni G; Ceppe A; Ford AA; Alexis NE; Barr RG; Bleecker ER; Christenson SA; Cooper CB; Han MK; Hansel NN; Hastie AT; Hoffman EA; Kanner RE; Martinez FJ; Ozkan E; Paine R; Woodruff PG; O'Neal WK; Boucher RC; Kesimer M
    Lancet Respir Med; 2021 Nov; 9(11):1241-1254. PubMed ID: 34058148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Serum Fractalkine/CX3CL1 in Patients with Chronic Obstructive Pulmonary Disease: Relationship with Emphysema Severity and Frequent Exacerbation.
    Hao W; Li M; Zhang C; Zhang Y; Xue Y
    Lung; 2019 Feb; 197(1):29-35. PubMed ID: 30382361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary Artery Abnormalities in Ex-smokers with and without Airflow Obstruction.
    Lindenmaier TJ; Kirby M; Paulin G; Mielniczuk L; Cunningham IA; Mura M; Licskai C; Parraga G
    COPD; 2016; 13(2):224-34. PubMed ID: 26606693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease].
    Kong YJ; Sun WX; Zhang YM; Shi YZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Feb; 31(2):129-33. PubMed ID: 18683786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum angiopoietin-like 4 is over-expressed in COPD patients: association with pulmonary function and inflammation.
    Wu YQ; Shen YC; Wang H; Zhang JL; Li DD; Zhang X; Wang T; Xu D; Ying BW; Wang LL; Wen FQ
    Eur Rev Med Pharmacol Sci; 2016; 20(1):44-53. PubMed ID: 26813452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: relationship to disease severity.
    Chaudhuri R; McSharry C; Brady J; Donnelly I; Grierson C; McGuinness S; Jolly L; Weir CJ; Messow CM; Spears M; Miele G; Nocka K; Crowther D; Thompson J; Brannigan M; Lafferty J; Sproule M; Macnee W; Connell M; Murchison JT; Shepherd MC; Feuerstein G; Miller DK; Thomson NC
    J Allergy Clin Immunol; 2012 Mar; 129(3):655-663.e8. PubMed ID: 22305682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory markers and circulating extracellular matrix proteins in patients with chronic obstructive pulmonary disease and left ventricular diastolic dysfunction.
    López-Sánchez M; Muñoz-Esquerre M; Huertas D; Montes A; Molina-Molina M; Manresa F; Dorca J; Santos S
    Clin Respir J; 2017 Nov; 11(6):859-866. PubMed ID: 26663885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
    Long H; Luo H; Chen P; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble receptor for advanced glycation end-products and progression of airway disease.
    Iwamoto H; Gao J; Pulkkinen V; Toljamo T; Nieminen P; Mazur W
    BMC Pulm Med; 2014 Apr; 14():68. PubMed ID: 24758342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin condition and its relationship to systemic inflammation in chronic obstructive pulmonary disease.
    Majewski S; Pietrzak A; Tworek D; Szewczyk K; Kumor-Kisielewska A; Kurmanowska Z; Górski P; Zalewska-Janowska A; Piotrowski WJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2407-2415. PubMed ID: 28860735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantitative analysis of emphysema and air trapping at inspiratory and expiratory phase multi-slice spiral CT scan in smokers: correlation with pulmonary function test].
    Zhang D; Guan Y; Fan L; Xia Y; Liu SY
    Zhonghua Yi Xue Za Zhi; 2018 May; 98(19):1467-1473. PubMed ID: 29804412
    [No Abstract]   [Full Text] [Related]  

  • 19. [Values of Body Mass Index and Chest CT Features in the Assessment of Chronic Obstructive Pulmonary Disease].
    Li L; Liu Y; Li J; Gao JM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):55-61. PubMed ID: 32131940
    [No Abstract]   [Full Text] [Related]  

  • 20. Is the COPD assessment test (CAT) effective in demonstrating the systemic inflammation and other components in COPD?
    Sarioglu N; Hismiogullari AA; Bilen C; Erel F
    Rev Port Pneumol (2006); 2016; 22(1):11-7. PubMed ID: 26534740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.